Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5410415
The anti-human, high molecular weight-melanoma associated antigen (HMW-MAA)MoAb 225.28S was chelated with /sup 111/In and then tested for its in vitro reactivity with cultured human melanoma cells and for its biodistribution in human melanoma bearing nude mice. In vitro studies showed that the radiolabeled antibody reacted specifically with cultured melanoma cells. However, binding of DTPA to the monoclonal antibody reduced its titer with cultured melanoma cells from 1:1024 to 1:512. Injection of the radiolabeled monoclonal antibody into nude mice resulted in the accumulation of significantly higher radioactivity in melanoma tissue than in nude mice injected with either (/sup 111/In)chloride or /sup 111/In-labeled antibody to human acid phosphatase. The localization of antibody in liver and kidney was also high, although lower than that achieved in tumor. These results indicate that /sup 111/In-labeled monoclonal antibodies to human tumor associated antigens may be useful for localizing malignant lesions. However, there is a need to improve labeling and/or purification of antibody in order to decrease renal and hepatic activity.
Research Organization:
Columbia Univ., New York
OSTI ID:
5410415
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 26:5; ISSN JNMEA
Country of Publication:
United States
Language:
English